'김갑성' 기자의 전체기사
-
Unlock the Future of Health and Food Innovation: Hi & Fi Asia-…
SHANGHAI, Jan. 27, 2026 -- Leveraging the solid foundation laid by its highly renowned 2025 edition, Hi & Fi Asia-China, Asia's premier platform for health ingredients and food innovation, is delighted to announce the official launch of pre-registration for its 2026 edition. Scheduled to be held from 15-17 June 2026 at the National Exhibition and Convention Center (NECC) Shanghai, the event will serve as a vital hub for global industry leaders, innovators, and decision-makers to converge, collaborate, and explore new possibilities in the dynamic food and health innovation landscape.
- 김갑성 기자
- 2026-01-27 10:00
-
Alphamab Oncology Announces the Results of a Phase III C…
SUZHOU, China, Jan. 27, 2026 -- Alphamab Oncology (Stock Code: 9966.HK) announced that the results from a phase III clinical study for the treatment of HER2-positive gastric or gastroesophageal junction cancer (GC/GEJ) of anbenitamab injection (KN026), independently developed by the Company and co-developed with JMT-Bio Technology Co., Ltd., a wholly-owned subsidiary of CSPC Pharmaceutical Group Co., Ltd. (stock code: 1093.HK), were recently published in the top-tier oncology journal Annals of Oncology (IF:65.4). The publication is titled: "Anbenitamab in previously treated HER2-positive
- 김갑성 기자
- 2026-01-27 09:58
-
ICP DAS-BMP at WHX Dubai 2026 Spotlights Low-Migration and Low…
HSINCHU, Jan. 27, 2026 -- ICP DAS-BMP (Biomedical Polymers), a Taiwan-based manufacturer and supplier of medical-grade TPU (thermoplastic polyurethane), is pleased to announce its participation in WHX Dubai 2026 (formerly Arab Health), taking place from 9 to 12 February at the Dubai Exhibition Centre. Visitors can find the ICP DAS-BMP team at Booth S7C117. The highlight of this year's exhibit will be two TPU innovations addressing critical needs in medical device manufacturing: the Low-Migration Series and the Low-Friction Series. The Low-Migration Arothane™ ARP-
- 김갑성 기자
- 2026-01-27 09:17
-
ICP DAS-BMP, WHX 두바이 2026서 저이행성•저마찰 TPU 기술 집중 조명
신주, 2026년 1월 27일 -- 대만에 본사를 둔 의료용 열가소성 폴리우레탄(TPU) 제조•공급업체 ICP DAS-BMP(ICP DAS-Biomedical Polymers)가 오는 2월 9일부터 12일까지 두바이 전시센터(Dubai Exhibition Centre)에서 열리는 WHX 두바이(WHX Dubai, 구 아랍 헬스) 2026에 참가한다고 밝혔다. 방문객은 부스 S7C117에서 ICP DAS-BMP 팀을 만날 수 있다. 이번 전시의 핵심은 의료기기 제조 분야에서 필수 과제를 해결한 두 가지 혁신 TPU 제품군인 저이행(Low-Migration) 시리즈와 저마찰(Low-Friction) 시리즈다. 저이행 Arothane™ ARP-B20 TPU는 ISO 10993 표준을 준수하며, 최대 90일간 체내 이식이 가능하다. 가공 과정에서 첨가제 이행을 최소화해 카테터가 보관 수명 기간 동안 매끄러운 표면을 유지할 수 있으며, 다양한 색상 옵션을 제공해 유연한 맞춤형 설계가 가능하다. 저마찰 시리즈는 본질적으로 매끄러운 표면을 갖도록 설계돼 별도의 코팅이나 사후 처리가 필요 없다. 전량 TP
- 김갑성 기자
- 2026-01-27 09:17
-
New "MedTech Advance" Sourcing Directory Launches to S…
[ 메디채널 김갑성 기자 ] Comprehensive e-book accelerates product development by connecting R&D and procurement teams with global suppliers. TAICHUNG, Jan. 27, 2026 -- Today marks the official release of MedTech Advance, a comprehensive digital buyer's directory engineered to accelerate the sourcing process for the medical technology industry. As the complexity of medical device design increases, MedTech Advance provides a centralized platform for Engineering, R&D, and Procurement professionals to discover elite suppliers and high-precision components. "Speed-to-ma
- 김갑성 기자
- 2026-01-27 09:00
-
Heartbeats Shareholder Mr Lu Min Yong Honoured as "Globa…
SYDNEY and BEIJING, Jan. 27, 2026 -- Heartbeats proudly congratulates its shareholder, Lu Min Yong, on being awarded the title of "全球华人楷模" (Global Chinese Role Model) at the Global Chinese Spring Festival Gala Evening held as part of the 2026 Chinese New Year celebrations in Beijing, China. This honour recognises Mr Yong's exceptional contribution to business leadership, cross-border collaboration, and nation-building infrastructure, most notably through his leadership of CREGA Australia Pty Ltd, which played a critical role in Australia's landmark Sydney Western Harb
- 김갑성 기자
- 2026-01-27 08:08
-
Innovent Announces IBI3003 (GPRC5D/BCMA/CD3 Trispecific Antib…
SAN FRANCISCO and SUZHOU, China, Jan. 27, 2026 -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures, and commercializes high-quality medicines for the treatment of oncologic, autoimmune, cardiovascular and metabolic, ophthalmologic, and other major diseases, announced that its anti-GPRC5D/BCMA/CD3 tri-specific antibody IBI3003 has received Fast Track Designation (FTD) from the U.S. Food and Drug Administration (FDA). This designation applies to the treatment of relapsed or refractory multiple myeloma, (R/R MM) in
- 김갑성 기자
- 2026-01-27 08:00
-
Dimora Medical Named Amazon Best Seller in Wound Dressin…
NEW YORK, Jan. 27, 2026 -- Dimora Medical, a continuous innovator in high-end medical care supplies, has been named a 2025 Amazon Best Seller in the Wound Dressings category, marking the fourth consecutive year the brand has held this distinction. The continued recognition underscores that Dimora Medical has earned widespread trust from consumers for combining clinical-grade functionality with everyday usability. Among the products contributing to this achievement is the Dimora Sacrum Silicone Foam Dressing with Border, one of the brand's top-performing items on Amazon. Designe
- 김갑성 기자
- 2026-01-27 02:50
-
신젠 인터내셔널, 브리스톨 마이어스 스퀴브와의 장기 연구 협력 2035년까지 연장
벵갈루루, 인도, 2026년 1월 27일 -- 글로벌 계약 연구•개발•제조 기관(CRDMO)인 신젠 인터내셔널(Syngene International)이 브리스톨 마이어스 스퀴브(Bristol Myers Squibb, BMS)와의 장기 전략적 협력 관계를 2035년까지 연장한다고 20일 발표했다. 이번 연장 협약에선 연구에서 상용화에 이르는 원활한 진행을 가능하게 하기 위해, 발견(화학, 생물학, 약물 대사 및 약동학), 중개 과학, 제약 개발 및 제조, 임상 시험, 데이터 및 정보 기술 서비스에 이르는 의약품 개발 라이프사이클 전반에 걸친 통합 서비스의 범위를 확대한다. 이번 협력 확대는 성장의 다음 단계를 의미하며, 통합된 종단간 과학 및 제조 솔루션을 제공하는 전략적 파트너로서 신젠 인터내셔널의 입지를 강화한다. 신젠 인터내셔널의 피터 베인즈(Peter Bains) 전무이사 겸 CEO는 "신젠과 브리스톨 마이어스 스퀴브 간 협력은 25년 이상 지속되어 왔으며, 과학적 탁월성, 운영의 신뢰성, 혁신적인 치료법 발전을 위한 공동의 의지를 기반으로 한다"면서 "2035년까지 양사간 협업을 연장하기로 한
- 김갑성 기자
- 2026-01-27 01:34
-
Functional Medicine Malaysia: Emagene Life Academy Offic…
KUALA LUMPUR, Malaysia, Jan. 26, 2026 -- Emagene Life, a leading functional medicine and longevity practice in Malaysia, has officially launched the Emagene Life Academy, marking a major milestone in the advancement of functional medicine education in the region. The Academy's launch was celebrated with the successful completion of its inaugural workshop, "Good Gut Gathering," a community-focused event centred on gut health, root-cause medicine, and long-term wellness. As a recognised leader in Functional Medicine Malaysia, Emagene Life continues to expand its mission
- 김갑성 기자
- 2026-01-27 00:37
- 1포리프 굿마팻 (누바디 굿바이 마이팻) 다이어트 건강기능식품 출시
- 22021년 식품분석전문가 1급/2급 검정자격시험 안내
- 3투썸플레이스, 초콜릿 애프리콧 무스 출시
- 4아임웹, CRM 기능 출시… 고객 행동 데이터 기반 마케팅 지원
- 5하만카돈, AURA STUDIO 4 블루투스 스피커 출시
- 6대구오페라하우스 - 20주년 기념 골든 보이스 시리즈Ⅲ, 테너 콘서트
- 7만성질환자들의 유료독감백신접종에 정책적인 배려가 필요하다
- 82021년 대학생기자단 모집
- 9대한약물영양의학회 2020년 추계학술대회
- 10대한영양제처방학회 춘계학술대회 성황리에 마쳐
2026-01-31_SAT
- CANADA BACKS NEW DEFENCE, SECURITY AND RESILIENCE BANK 12:05
- Origin Agritech Announces Fiscal Year 2025 Results 06:00
- White Pearl Acquisition Corp. Announces Pricing of $100 Million Initial Public Offering 05:47
- Planet Green Holdings Corp. Provides Response to Unusual Market Action 05:05
- SKF completes previously announced divestment of non-core aerospace operation in Elgin, USA 03:36
- DOCOMO Concludes Partnership Agreement with Aduna to Advance Global Network API Expansion 03:34
- Photo Dance: Making AI Dance Trends Accessible to Everyone - How This App Lets Ordinary Users Join the Dance Wave Without Appearing On Camera 00:00
발행인 : 최희정 | 편집인 : 김갑성 |
등록번호: 서울특별시 아53302 | 등록일 2020-09-25 | 전화번호 02-565-7119 |
주소 : 서울특별시 강남구 영동대로 602, 6층 E115 (삼성동)
Copyright @메디채널 Corp. All rights reserved.
UPDATE: 2026년 01월 31일 13시 40분